X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (560) 560
Publication (31) 31
Book Review (5) 5
Book Chapter (3) 3
Book / eBook (1) 1
Data Set (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (425) 425
female (385) 385
breast cancer (318) 318
oncology (282) 282
breast neoplasms - pathology (281) 281
index medicus (254) 254
middle aged (242) 242
infiltrating lobular carcinoma (224) 224
aged (198) 198
cancer (197) 197
adult (183) 183
prognosis (179) 179
pathology (134) 134
tumor-infiltrating lymphocytes (117) 117
immunohistochemistry (104) 104
tumors (98) 98
aged, 80 and over (92) 92
carcinoma, ductal, breast - pathology (90) 90
lymphocytes (89) 89
chemotherapy (87) 87
carcinoma, lobular - pathology (84) 84
surgery (80) 80
metastasis (79) 79
neoplasm staging (78) 78
survival (78) 78
carcinoma (72) 72
medicine & public health (71) 71
research (71) 71
expression (70) 70
analysis (69) 69
breast neoplasms - metabolism (68) 68
retrospective studies (65) 65
breast (63) 63
breast neoplasms - immunology (59) 59
breast neoplasms - mortality (58) 58
care and treatment (58) 58
lymphocytes, tumor-infiltrating - pathology (58) 58
lymphocytes, tumor-infiltrating - immunology (56) 56
breast neoplasms - surgery (52) 52
diagnosis (47) 47
breast neoplasms - genetics (46) 46
t cells (46) 46
breast carcinoma (45) 45
metastases (44) 44
development and progression (43) 43
immunotherapy (43) 43
infiltrating ductal carcinoma (43) 43
patients (43) 43
neoplasm invasiveness (42) 42
neoadjuvant chemotherapy (41) 41
mammography (40) 40
medical prognosis (40) 40
breast neoplasms - diagnosis (39) 39
breast neoplasms - drug therapy (39) 39
biopsy (38) 38
gene expression (38) 38
lymphatic metastasis (38) 38
therapy (38) 38
biomarkers, tumor - analysis (37) 37
health aspects (37) 37
survival rate (37) 37
risk factors (36) 36
women (36) 36
breast neoplasms - therapy (35) 35
follow-up studies (35) 35
mastectomy (35) 35
cancer therapies (34) 34
survival analysis (34) 34
neoplasm grading (33) 33
obstetrics & gynecology (33) 33
cancer research (32) 32
male (32) 32
radiology, nuclear medicine & medical imaging (32) 32
treatment outcome (32) 32
breast neoplasms (31) 31
in-situ (31) 31
recurrence (31) 31
disease-free survival (30) 30
ductal carcinoma (30) 30
medical research (30) 30
biomarkers (29) 29
carcinoma, ductal, breast - surgery (29) 29
carcinoma, intraductal, noninfiltrating - pathology (29) 29
carcinoma, lobular - secondary (29) 29
immunology (29) 29
invasiveness (29) 29
risk (29) 29
abridged index medicus (28) 28
lymphocytes t (28) 28
neoplasm metastasis (28) 28
skin and connective tissue diseases (28) 28
breast neoplasms - diagnostic imaging (27) 27
cancer patients (27) 27
diagnosis, differential (27) 27
receptors, estrogen - metabolism (27) 27
cells (26) 26
estrogen (26) 26
estrogen-receptor (26) 26
infiltrating lymphocytes (26) 26
t-cells (26) 26
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (541) 541
German (8) 8
French (5) 5
Spanish (4) 4
Italian (3) 3
Polish (3) 3
Chinese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Breast cancer research : BCR, ISSN 1465-5411, 02/2004, Volume 6, Issue 3, pp. R149 - 156
Introduction: Invasive lobular carcinoma (ILC) comprises approximately 10% of breast cancers and appears to have a distinct biology. Because it is less common... 
Breast carcinoma | Infiltrating ductal carcinoma | Invasive ductal carcinoma of the breast | Special type of breast cancer | Invasive lobular carcinoma of the breast | Breast cancer | Infiltrating lobular carcinoma | special type of breast cancer | PROGNOSTIC FACTORS | infiltrating lobular carcinoma | invasive ductal carcinoma of the breast | invasive lobular carcinoma of the breast | infiltrating ductal carcinoma | METASTATIC PATTERNS | breast cancer | HISTOLOGIC FEATURES | CANCER | INVASIVE DUCTAL CARCINOMA | STEROID-RECEPTORS | S-PHASE FRACTION | ONCOLOGY | breast carcinoma | MAMMOGRAPHIC FINDINGS | EPIDEMIOLOGIC RISK-FACTORS | DNA FLOW-CYTOMETRY | Neoplasms, Hormone-Dependent - mortality | Carcinoma, Lobular - pathology | Prognosis | Follow-Up Studies | Humans | Middle Aged | Receptors, Estrogen - analysis | Life Tables | Carcinoma, Ductal, Breast - mortality | Carcinoma, Ductal, Breast - chemistry | Carcinoma, Lobular - mortality | Receptors, Progesterone - analysis | Tumor Suppressor Protein p53 - analysis | Breast Neoplasms - chemistry | Neoplasm Metastasis | Neoplasms, Hormone-Dependent - chemistry | Adult | Carcinoma, Ductal, Breast - pathology | Female | Carcinoma, Ductal, Breast - secondary | Carcinoma, Lobular - secondary | Proportional Hazards Models | Survival Rate | Treatment Outcome | Receptor, Epidermal Growth Factor - analysis | Carcinoma, Lobular - chemistry | Disease-Free Survival | Breast Neoplasms - pathology | Neoplasms, Hormone-Dependent - pathology | Survival Analysis | Breast Neoplasms - mortality | Neoplasm Proteins - analysis | Aged | Receptor, ErbB-2 - analysis | Medical colleges | Carcinoma | Epidermal growth factor | Patient outcomes | Estrogen | Progesterone | Tumor proteins | Cancer
Journal Article
Journal Article
Diagnostic Pathology, ISSN 1746-1596, 08/2018, Volume 13, Issue 1, pp. 62 - 6
Background: Breast carcinoma with osteoclast-like giant cells (OGCs) is infrequent, being most reported cased described as ductal invasive carcinomas. Invasive... 
Lobular carcinoma | Breast cancer | Pleomorphic carcinoma | Osteoclast-like giant cells | INTERNATIONAL EXPERT CONSENSUS | PRIMARY THERAPY | DIGITAL PATHOLOGY | PROLIFERATION | PATHOLOGY | PROGNOSTIC VALUE | REPRODUCIBILITY | KI-67 | CANCER HIGHLIGHTS | KI67 | EXPRESSION | Immunohistochemistry | Carcinoma, Lobular - pathology | Humans | Antigens, CD - genetics | Osteoclasts - chemistry | Antigens, CD - analysis | Breast Neoplasms - therapy | Breast Neoplasms - chemistry | Keratins - analysis | Carcinoma, Lobular - therapy | Carcinoma, Lobular - genetics | DNA Mutational Analysis | Mastectomy | Female | Lymphocytes, Tumor-Infiltrating - chemistry | Chemotherapy, Adjuvant | T-Lymphocytes - pathology | Cadherins - genetics | Osteoclasts - pathology | Giant Cells - chemistry | Biomarkers, Tumor - analysis | Cadherins - analysis | Treatment Outcome | Carcinoma, Lobular - chemistry | Breast Neoplasms - genetics | Lymphocytes, Tumor-Infiltrating - pathology | Breast Neoplasms - pathology | T-Lymphocytes - chemistry | Aged | Biomarkers, Tumor - genetics | Mutation | Giant Cells - pathology | Women | Care and treatment | Prognosis | Analysis | Research | T cells | Giant cell tumors | Health aspects | Mesenchyme | CD8 antigen | Lymphocytes T | E-cadherin | Metastases | Gene sequencing | Literature reviews | Breast carcinoma | Keratin | Histopathology | Lymphocytes | Biocompatibility | Giant cells | Diagnosis | Lymphatic system | Invasiveness | Mammography | CD4 antigen | Biopsy | Morphology | Growth patterns | Breast | Infiltration | Pleomorphism | Tumors
Journal Article
World Journal of Gastroenterology, ISSN 1007-9327, 03/2009, Volume 15, Issue 11, pp. 1388 - 1390
Journal Article
Indian Journal of Cancer, ISSN 0019-509X, 07/2016, Volume 53, Issue 3, pp. 363 - 365
INTRODUCTION: Invasive lobular carcinoma (ILC) is the second most common type of breast cancer accounting for 5%-15% of all the breast cancer cases. The... 
infiltrating | lobular | Balochistan | invasive lobular carcinoma | carcinoma | breast | SUSCEPTIBILITY | PAKISTAN | METASTATIC PATTERN | THERAPY | ONCOLOGY | SARCOMAS | DUCTAL CARCINOMA
Journal Article
Annals of Oncology, ISSN 0923-7534, 2015, Volume 26, Issue 8, pp. 1533 - 1546
The 14th St Gallen International Breast Cancer Conference (2015) reviewed substantial new evidence on locoregional and systemic therapies for early breast... 
Radiation therapy | Early breast cancer | St Gallen Consensus | Systemic adjuvant therapies | Surgery | early breast cancer | ADJUVANT CHEMOTHERAPY | ENDOCRINE THERAPY | PREMENOPAUSAL WOMEN | ESTROGEN-RECEPTOR | PATHOLOGICAL COMPLETE RESPONSE | TUMOR-INFILTRATING LYMPHOCYTES | OVARIAN-FUNCTION SUPPRESSION | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | radiation therapy | SENTINEL NODE | CONTRALATERAL PROPHYLACTIC MASTECTOMY | systemic adjuvant therapies | surgery | Carcinoma, Lobular - pathology | Receptors, Estrogen - metabolism | Humans | Carcinoma, Intraductal, Noninfiltrating - metabolism | Mastectomy - methods | Receptor, ErbB-2 - metabolism | Tamoxifen - administration & dosage | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Breast Neoplasms - therapy | Anthracyclines - administration & dosage | Carcinoma, Lobular - therapy | Carcinoma, Intraductal, Noninfiltrating - therapy | Antineoplastic Agents, Hormonal - therapeutic use | Axilla | Carcinoma, Ductal, Breast - pathology | Female | Carcinoma, Ductal, Breast - metabolism | Mastectomy, Segmental - methods | Trastuzumab - administration & dosage | Carcinoma, Ductal, Breast - therapy | Taxoids - administration & dosage | Carcinoma, Intraductal, Noninfiltrating - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Chemotherapy, Adjuvant - methods | Radiotherapy, Adjuvant - methods | Carcinoma, Lobular - metabolism | Platinum Compounds - administration & dosage | Lymph Node Excision - methods | Neoplasm Staging | Practice Guidelines as Topic | Special
Journal Article